The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Ex Vivo Human Skin Models Market Research Report 2025

Global Ex Vivo Human Skin Models Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1898542

No of Pages : 91

Ask Your Query
Synopsis
Compared with in vitro skin models, ex vivo models can be more accurate on representing the human skin in some case, such as the effect of the extracellular matrix (ECM) in terms of structure, cell signaling mechanisms and the processes of metabolism, the incorporation of skin appendages such as hair follicles and sweat glands, and the effects of dermal absorption. Ex vivo human skin is more appropriate for certain types of research, use of whole skin biopsies in culture allows the effect of individual ingredients and formulations, transdermal delivery, topical penetration and percutaneous absorption to be tested in an environment more closely mimicking normal skin.
The global Ex Vivo Human Skin Models market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ex Vivo Human Skin Models is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ex Vivo Human Skin Models is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ex Vivo Human Skin Models include Genoskin, MatTek Life Sciences, Creative Bioarray, EpiSkin, Reprocell, Alcyomics, Epistem, QIMA Life Sciences and Extherid Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ex Vivo Human Skin Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ex Vivo Human Skin Models.
Report Scope
The Ex Vivo Human Skin Models market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ex Vivo Human Skin Models market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ex Vivo Human Skin Models manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genoskin
MatTek Life Sciences
Creative Bioarray
EpiSkin
Reprocell
Alcyomics
Epistem
QIMA Life Sciences
Extherid Biosciences
Perfectus Biomed
Xenometrix
Syntivia
Creative Biolabs
Segment by Type
Products
Customized Testing Services
Segment by Application
Pharmaceutical
Cosmetic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ex Vivo Human Skin Models manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ex Vivo Human Skin Models in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Ex Vivo Human Skin Models Market Overview
1.1 Product Overview and Scope of Ex Vivo Human Skin Models
1.2 Ex Vivo Human Skin Models Segment by Type
1.2.1 Global Ex Vivo Human Skin Models Market Value Comparison by Type (2024-2030)
1.2.2 Products
1.2.3 Customized Testing Services
1.3 Ex Vivo Human Skin Models Segment by Application
1.3.1 Global Ex Vivo Human Skin Models Market Value by Application: (2024-2030)
1.3.2 Pharmaceutical
1.3.3 Cosmetic
1.3.4 Others
1.4 Global Ex Vivo Human Skin Models Market Size Estimates and Forecasts
1.4.1 Global Ex Vivo Human Skin Models Revenue 2019-2030
1.4.2 Global Ex Vivo Human Skin Models Sales 2019-2030
1.4.3 Global Ex Vivo Human Skin Models Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ex Vivo Human Skin Models Market Competition by Manufacturers
2.1 Global Ex Vivo Human Skin Models Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ex Vivo Human Skin Models Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ex Vivo Human Skin Models Average Price by Manufacturers (2019-2024)
2.4 Global Ex Vivo Human Skin Models Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ex Vivo Human Skin Models, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ex Vivo Human Skin Models, Product Type & Application
2.7 Ex Vivo Human Skin Models Market Competitive Situation and Trends
2.7.1 Ex Vivo Human Skin Models Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ex Vivo Human Skin Models Players Market Share by Revenue
2.7.3 Global Ex Vivo Human Skin Models Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ex Vivo Human Skin Models Retrospective Market Scenario by Region
3.1 Global Ex Vivo Human Skin Models Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ex Vivo Human Skin Models Global Ex Vivo Human Skin Models Sales by Region: 2019-2030
3.2.1 Global Ex Vivo Human Skin Models Sales by Region: 2019-2024
3.2.2 Global Ex Vivo Human Skin Models Sales by Region: 2025-2030
3.3 Global Ex Vivo Human Skin Models Global Ex Vivo Human Skin Models Revenue by Region: 2019-2030
3.3.1 Global Ex Vivo Human Skin Models Revenue by Region: 2019-2024
3.3.2 Global Ex Vivo Human Skin Models Revenue by Region: 2025-2030
3.4 North America Ex Vivo Human Skin Models Market Facts & Figures by Country
3.4.1 North America Ex Vivo Human Skin Models Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ex Vivo Human Skin Models Sales by Country (2019-2030)
3.4.3 North America Ex Vivo Human Skin Models Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ex Vivo Human Skin Models Market Facts & Figures by Country
3.5.1 Europe Ex Vivo Human Skin Models Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ex Vivo Human Skin Models Sales by Country (2019-2030)
3.5.3 Europe Ex Vivo Human Skin Models Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Ex Vivo Human Skin Models Market Facts & Figures by Country
3.6.1 Asia Pacific Ex Vivo Human Skin Models Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ex Vivo Human Skin Models Sales by Country (2019-2030)
3.6.3 Asia Pacific Ex Vivo Human Skin Models Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Ex Vivo Human Skin Models Market Facts & Figures by Country
3.7.1 Latin America Ex Vivo Human Skin Models Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ex Vivo Human Skin Models Sales by Country (2019-2030)
3.7.3 Latin America Ex Vivo Human Skin Models Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Ex Vivo Human Skin Models Market Facts & Figures by Country
3.8.1 Middle East and Africa Ex Vivo Human Skin Models Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ex Vivo Human Skin Models Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ex Vivo Human Skin Models Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ex Vivo Human Skin Models Sales by Type (2019-2030)
4.1.1 Global Ex Vivo Human Skin Models Sales by Type (2019-2024)
4.1.2 Global Ex Vivo Human Skin Models Sales by Type (2025-2030)
4.1.3 Global Ex Vivo Human Skin Models Sales Market Share by Type (2019-2030)
4.2 Global Ex Vivo Human Skin Models Revenue by Type (2019-2030)
4.2.1 Global Ex Vivo Human Skin Models Revenue by Type (2019-2024)
4.2.2 Global Ex Vivo Human Skin Models Revenue by Type (2025-2030)
4.2.3 Global Ex Vivo Human Skin Models Revenue Market Share by Type (2019-2030)
4.3 Global Ex Vivo Human Skin Models Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ex Vivo Human Skin Models Sales by Application (2019-2030)
5.1.1 Global Ex Vivo Human Skin Models Sales by Application (2019-2024)
5.1.2 Global Ex Vivo Human Skin Models Sales by Application (2025-2030)
5.1.3 Global Ex Vivo Human Skin Models Sales Market Share by Application (2019-2030)
5.2 Global Ex Vivo Human Skin Models Revenue by Application (2019-2030)
5.2.1 Global Ex Vivo Human Skin Models Revenue by Application (2019-2024)
5.2.2 Global Ex Vivo Human Skin Models Revenue by Application (2025-2030)
5.2.3 Global Ex Vivo Human Skin Models Revenue Market Share by Application (2019-2030)
5.3 Global Ex Vivo Human Skin Models Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Genoskin
6.1.1 Genoskin Corporation Information
6.1.2 Genoskin Description and Business Overview
6.1.3 Genoskin Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Genoskin Ex Vivo Human Skin Models Product Portfolio
6.1.5 Genoskin Recent Developments/Updates
6.2 MatTek Life Sciences
6.2.1 MatTek Life Sciences Corporation Information
6.2.2 MatTek Life Sciences Description and Business Overview
6.2.3 MatTek Life Sciences Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.2.4 MatTek Life Sciences Ex Vivo Human Skin Models Product Portfolio
6.2.5 MatTek Life Sciences Recent Developments/Updates
6.3 Creative Bioarray
6.3.1 Creative Bioarray Corporation Information
6.3.2 Creative Bioarray Description and Business Overview
6.3.3 Creative Bioarray Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Creative Bioarray Ex Vivo Human Skin Models Product Portfolio
6.3.5 Creative Bioarray Recent Developments/Updates
6.4 EpiSkin
6.4.1 EpiSkin Corporation Information
6.4.2 EpiSkin Description and Business Overview
6.4.3 EpiSkin Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EpiSkin Ex Vivo Human Skin Models Product Portfolio
6.4.5 EpiSkin Recent Developments/Updates
6.5 Reprocell
6.5.1 Reprocell Corporation Information
6.5.2 Reprocell Description and Business Overview
6.5.3 Reprocell Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Reprocell Ex Vivo Human Skin Models Product Portfolio
6.5.5 Reprocell Recent Developments/Updates
6.6 Alcyomics
6.6.1 Alcyomics Corporation Information
6.6.2 Alcyomics Description and Business Overview
6.6.3 Alcyomics Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Alcyomics Ex Vivo Human Skin Models Product Portfolio
6.6.5 Alcyomics Recent Developments/Updates
6.7 Epistem
6.6.1 Epistem Corporation Information
6.6.2 Epistem Description and Business Overview
6.6.3 Epistem Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Epistem Ex Vivo Human Skin Models Product Portfolio
6.7.5 Epistem Recent Developments/Updates
6.8 QIMA Life Sciences
6.8.1 QIMA Life Sciences Corporation Information
6.8.2 QIMA Life Sciences Description and Business Overview
6.8.3 QIMA Life Sciences Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.8.4 QIMA Life Sciences Ex Vivo Human Skin Models Product Portfolio
6.8.5 QIMA Life Sciences Recent Developments/Updates
6.9 Extherid Biosciences
6.9.1 Extherid Biosciences Corporation Information
6.9.2 Extherid Biosciences Description and Business Overview
6.9.3 Extherid Biosciences Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Extherid Biosciences Ex Vivo Human Skin Models Product Portfolio
6.9.5 Extherid Biosciences Recent Developments/Updates
6.10 Perfectus Biomed
6.10.1 Perfectus Biomed Corporation Information
6.10.2 Perfectus Biomed Description and Business Overview
6.10.3 Perfectus Biomed Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Perfectus Biomed Ex Vivo Human Skin Models Product Portfolio
6.10.5 Perfectus Biomed Recent Developments/Updates
6.11 Xenometrix
6.11.1 Xenometrix Corporation Information
6.11.2 Xenometrix Ex Vivo Human Skin Models Description and Business Overview
6.11.3 Xenometrix Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Xenometrix Ex Vivo Human Skin Models Product Portfolio
6.11.5 Xenometrix Recent Developments/Updates
6.12 Syntivia
6.12.1 Syntivia Corporation Information
6.12.2 Syntivia Ex Vivo Human Skin Models Description and Business Overview
6.12.3 Syntivia Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Syntivia Ex Vivo Human Skin Models Product Portfolio
6.12.5 Syntivia Recent Developments/Updates
6.13 Creative Biolabs
6.13.1 Creative Biolabs Corporation Information
6.13.2 Creative Biolabs Ex Vivo Human Skin Models Description and Business Overview
6.13.3 Creative Biolabs Ex Vivo Human Skin Models Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Creative Biolabs Ex Vivo Human Skin Models Product Portfolio
6.13.5 Creative Biolabs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ex Vivo Human Skin Models Industry Chain Analysis
7.2 Ex Vivo Human Skin Models Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ex Vivo Human Skin Models Production Mode & Process
7.4 Ex Vivo Human Skin Models Sales and Marketing
7.4.1 Ex Vivo Human Skin Models Sales Channels
7.4.2 Ex Vivo Human Skin Models Distributors
7.5 Ex Vivo Human Skin Models Customers
8 Ex Vivo Human Skin Models Market Dynamics
8.1 Ex Vivo Human Skin Models Industry Trends
8.2 Ex Vivo Human Skin Models Market Drivers
8.3 Ex Vivo Human Skin Models Market Challenges
8.4 Ex Vivo Human Skin Models Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock